40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 09
00:56 UTC
|
CPT
Camden Property Trust
|
◎ Target | Vikram Malhorta not yet tracked | Outperform | $125.00→ $116.00-7.2% |
|
Sep 09
00:56 UTC
|
CMS
CMS Energy
|
◎ Target | James Thalacker ★★★★☆ #941 | Outperform | $82.00→ $77.00-6.1% |
|
Sep 09
00:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $24.00→ $30.00+25.0% |
|
Sep 09
00:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Leland Gershell ★☆☆☆☆ #3036 | Outperform | $18.00→ $25.00+38.9% |
|
Sep 09
00:56 UTC
|
CDW
CDW
|
◎ Target | Tim Long ★★★☆☆ #1563 | Equal Weight | $123.00→ $150.00+22.0% |
|
Sep 09
00:56 UTC
|
BBOX
Tritax Big Box REIT
|
◎ Target | firm only | Buy | GBX 196→ GBX 188-4.1% |
|
Sep 09
00:56 UTC
|
APP
AppLovin
|
◎ Target | Clark Lampen ★★☆☆☆ #2834 | Buy | $408.00→ $396.00-2.9% |
|
Sep 09
00:56 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Faisal Khurshid ★★★☆☆ #2184 | Hold | $230.00→ $260.00+13.0% |
|
Sep 09
00:56 UTC
|
ABSI
Absci
|
◎ Target | Kambiz Yazdi ★★★☆☆ #1781 | Buy | $13.00→ $16.00+23.1% |
|
Sep 09
00:56 UTC
|
ABNB
Airbnb
|
◎ Target | Colin Sebastian ★★★☆☆ #986 | Outperform | $175.00→ $200.00+14.3% |
|
Sep 08
19:56 UTC
|
ZS
Zscaler
|
◎ Target | Fatima Boolani ★★★★★ #92 | Buy | $175.00→ $205.00+17.1% |
|
Sep 08
19:56 UTC
|
TARS
Tarsus Pharmaceuticals
|
◎ Target | Anthony Petrone ★★★★☆ #380 | Buy | $88.00→ $105.00+19.3% |
|
Sep 08
19:56 UTC
|
DOO
BRP
|
◎ Target | James Hardiman ★★☆☆☆ #2586 | Buy | $74.00→ $77.00+4.1% |
|
Sep 08
18:56 UTC
|
VLY
Valley National Bancorp
|
◎ Target | Manan Gosalia ★★★★☆ #851 | Equal Weight | $16.00→ $17.00+6.2% |
|
Sep 08
18:56 UTC
|
UMBF
UMB Financial
|
◎ Target | Brian Wilczynski ★★★★☆ #846 | Overweight | $159.00→ $190.00+19.5% |
|
Sep 08
18:56 UTC
|
RF
Regions Financial
|
◎ Target | Betsy Graseck not yet tracked | Equal Weight | $35.00→ $36.00+2.9% |
|
Sep 08
18:56 UTC
|
ONTO
Onto Innovation
|
◎ Target | Shane Brett not yet tracked | Overweight | $383.00→ $360.00-6.0% |
|
Sep 08
18:56 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Michael Ulz ★☆☆☆☆ #3014 | Overweight | $110.00→ $104.00-5.5% |
|
Sep 08
18:56 UTC
|
HNGE
Hinge Health
|
◎ Target | David Grossman ★★★★★ #98 | Buy | $96.00→ $115.00+19.8% |
|
Sep 08
18:56 UTC
|
EQBK
Equity Bancshares
|
◎ Target | Nathan Race ★★★★☆ #426 | Overweight | $58.00→ $60.00+3.4% |
|
Sep 08
18:56 UTC
|
DOO
BRP
|
◎ Target | firm only | Buy | C$106.00→ C$110.00+3.8% |
|
Sep 08
17:56 UTC
|
XPO
XPO
|
◎ Target | Ariel Rosa ★★★☆☆ #1307 | Neutral | $221.00→ $220.00-0.5% |
|
Sep 08
17:56 UTC
|
TH
Target Hospitality
|
◎ Target | Scott Schneeberger ★★★☆☆ #1973 | Outperform | $24.00→ $27.00+12.5% |
|
Sep 08
17:56 UTC
|
SAIA
Saia
|
◎ Target | Ariel Rosa ★★★☆☆ #1307 | Buy | $423.00→ $417.00-1.4% |
|
Sep 08
17:56 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Douglas Tsao ★★★☆☆ #1436 | Buy | $41.00→ $47.00+14.6% |
|
Sep 08
17:56 UTC
|
HOG
Harley-Davidson
|
◎ Target | James Hardiman ★★☆☆☆ #2586 | Neutral | $27.00→ $31.00+14.8% |
|
Sep 08
17:56 UTC
|
EGAN
eGain
|
◎ Target | Erik Suppiger ★★★★☆ #646 | Neutral | $10.50→ $6.00-42.9% |
|
Sep 08
17:56 UTC
|
DGX
Quest Diagnostics
|
◎ Target | Kevin Caliendo ★★★★☆ #882 | Neutral | $232.00→ $245.00+5.6% |
|
Sep 08
17:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Leland Gershell ★☆☆☆☆ #3036 | Outperform | $18.00→ $25.00+38.9% |
|
Sep 08
16:55 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Anupam Rama ★★☆☆☆ #2704 | Overweight | $76.00→ $83.00+9.2% |
|
Sep 08
16:55 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Vikram Malhorta not yet tracked | Neutral | $41.00→ $39.00-4.9% |
|
Sep 08
16:55 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Dennis Ding ★★☆☆☆ #2387 | Buy | $42.00→ $52.00+23.8% |
|
Sep 08
16:55 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Daniel Fannon ★★★☆☆ #1625 | Buy | $127.00→ $140.00+10.2% |
|
Sep 08
16:55 UTC
|
FDX
FedEx
|
◎ Target | Brian Ossenbeck ★★★☆☆ #1697 | Overweight | $460.00→ $400.00-13.0% |
|
Sep 08
16:55 UTC
|
CPT
Camden Property Trust
|
◎ Target | Vikram Malhorta not yet tracked | Outperform | $125.00→ $116.00-7.2% |
|
Sep 08
15:55 UTC
|
PTON
Peloton Interactive
|
◎ Target | Arpine Kocharyan ★★★☆☆ #1434 | Buy | $11.00→ $10.00-9.1% |
|
Sep 08
15:55 UTC
|
MPC
Marathon Petroleum
|
◎ Target | Manav Gupta ★★★★☆ #364 | Buy | $321.00→ $450.00+40.2% |
|
Sep 08
15:55 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Haendel St. Juste ★★☆☆☆ #2371 | Outperform | $152.00→ $140.00-7.9% |
|
Sep 08
15:55 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Mitchell Kapoor ★★★☆☆ #2186 | Buy | $115.00→ $100.00-13.0% |
|
Sep 08
15:55 UTC
|
HYPD
Hyperion DeFi
|
◎ Target | James McIlree ★☆☆☆☆ #2948 | Buy | $7.30→ $8.45+15.8% |
|
Sep 08
15:55 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Faisal Khurshid ★★★☆☆ #2184 | Hold | $230.00→ $260.00+13.0% |
|
Sep 08
14:55 UTC
|
VRSK
Verisk Analytics
|
◎ Target | Manav Patnaik ★★★★☆ #739 | Overweight | $275.00→ $225.00-18.2% |
|
Sep 08
14:55 UTC
|
VLO
Valero Energy
|
◎ Target | Manav Gupta ★★★★☆ #364 | Buy | $355.00→ $450.00+26.8% |
|
Sep 08
14:55 UTC
|
TRI
Thomson Reuters
|
◎ Target | Manav Patnaik ★★★★☆ #739 | Overweight | $140.00→ $130.00-7.1% |
|
Sep 08
14:55 UTC
|
SYM
Symbotic
|
◎ Target | Guy Hardwick ★★★★☆ #462 | Underweight | $44.00→ $38.00-13.6% |
|
Sep 08
14:55 UTC
|
SNX
TD SYNNEX
|
◎ Target | Guy Hardwick ★★★★☆ #462 | Equal Weight | $278.00→ $287.00+3.2% |
|
Sep 08
14:55 UTC
|
SLG
SL Green Realty
|
◎ Target | Brendan Lynch ★★★☆☆ #1934 | Equal Weight | $52.00→ $54.00+3.8% |
|
Sep 08
14:55 UTC
|
SAIC
Science Applications International
|
◎ Target | Gavin Parsons ★★★☆☆ #1876 | Sell | $93.00→ $103.00+10.8% |
|
Sep 08
14:55 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Michael Nedelcovych ★★★☆☆ #1140 | Buy | $65.00→ $68.00+4.6% |
|
Sep 08
14:55 UTC
|
PSX
Phillips 66
|
◎ Target | Manav Gupta ★★★★☆ #364 | Buy | $235.00→ $300.00+27.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.